Valvular & structural heart disease
Incremental Cost and Length of Stay Associated With Complications of Transcatheter Aortic Valve Replacement
Authors' conclusion
In contemporary practice, approximately one in 3 Medicare TAVR patients experience serious complications, substantially increasing hospital resource use. Despite improvements in TAVR outcomes and efficiency, additional cost savings can be achieved through complication mitigation.
Study context
- Population
- Medicare beneficiaries undergoing transcatheter aortic valve replacement (TAVR)Medicare beneficiaries undergoing TAVR, fiscal year 2020
- Participants
- 66,893 beneficiaries
- Comparison
- Patients who experience any of the complications compared to those not experiencing complications
- Outcome
- One or more complications
- Follow-up
- 2020
Methodological detailsMultivariable regression
- Multivariable regression
Main finding
As reported in the abstract
Experienced one or more complications
31.1%
Further findings
| Outcome | Estimate |
|---|---|
| Incremental cost and LOS with any complicationComplications vs No complications · increased costs | incremental cost $15,377 |
| Incremental cost and LOS with any complicationComplications vs No complications · increased | incremental LOS 2.8 days |
| Incremental cost and LOS with any complicationComplications vs No complications · After adjustments for patient risk factors | risk-adjusted incremental cost $12,953 |
Cost and length of stay (LOS) of TAVR hospitalization
- Mean cost of a TAVR hospitalization
- $54,988 ± $26,744
- Mean LOS
- 3.1 ± 4.5 days
Highest risk-adjusted costs by complication
- Surgical aortic valve replacement
- $42,924
- Acute renal failure requiring dialysis
- $34,606
- In-hospital mortality
- $25,307
Total additional costs from complications
- Additional costs
- $320 million
- Share of total hospital cost for Medicare TAVR patients
- 8.7%
Original publication
Incremental Cost and Length of Stay Associated With Complications of Transcatheter Aortic Valve Replacement. JACC Adv. Published 26 August 2025. doi:10. 1016/ j. jacadv. 2025. 102107
Composed by AI from the published abstract and checked against it. How Briefs are made →